Registry of Lobbyists

Registration - In-house Corporation

Merck Canada Inc. / David D. Jones, PRESIDENT

Registration Information

In-house Corporation name: Merck Canada Inc.
Previous in-house corporation names
Responsible Officer Name: David D. Jones, PRESIDENT 
Responsible Officer Change History
Initial registration start date: 2001-02-01
Registration status: Active
Registration Number: 959141-12241

Associated Communications

Total Number of Communication Reports: 198

Monthly communication reports in the last 6 months: 6

Version 3 of 45 (2003-02-14 to 2004-02-26)

Version 3 of 45 (2003-02-14 to 2004-02-26) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Lobbyist and Corporation

Corporation: MERCK FROSST CANADA INC
16711 TRANSCANADA HIGHWAY
KIRKLAND, QC  H9H 3L1
Canada
Telephone number: 514-428-3788
Fax number: 514-428-3892  
Responsible officer name and position during the period of this registration: DAWN GRAHAM, EXECUTIVE DIRECTOR, CORPORATE AFFAIRS  
Description of activities: MFCC IS ONE OF CANADA'S LARGEST RESEARCH-BASED PHARMACEUTICAL COMPANY WITH ROOTS GOING BACK TO 1899. THE COMPANY IS BASED IN KIRKLAND, QUEBEC WITH OFFICES IN HALIFAX, QUEBEC CITY, OTTAWA, WINNIPEG, CALGARY, EDMONTON AND VANCOUVER. OVER 1,700 PEOPLE ARE EMPLOYED IN THE DISCOVERY, MANUFACTURE AND MARKETING OF PRESCRIPTION MEDICINES. OUR CENTRE FOR THERAPEUTIC RESEARCH ALONE EMPLOYEES OVER 300 SCIENTISTS AND IS THE LARGES BIOMEDICAL RESEARCH CENTRE IN CANADA.
 
Parent: The corporation is not a subsidiary of any other parent corporations.
Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Federal Office of Regional Development – Quebec (FORD[Q]), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Justice Canada (JC), National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Solicitor General Canada (SGC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Constitutional Issues, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement
 
Subject Matter: Particulars: CHANGES TO PATENT LEGISLATION; PMPRB PRICING GUIDELINES; PHARMACARE; HEALTH POLICIES




Date Modified: